Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 25, 21:30 PM 2012  
FNMFO KDDIF 096770 AMKBF CTGBZ AU 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for CRIS and BGAIF ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Curis Inc.  and   BioGaia AB
Check Correlation Matrix  
Daily Returns (%)
CRIS  BGAIF  
Timeline
Given investment horizon of 30 days, Curis Inc. is expected to generate 0.49 times more return on investment than BioGaia. However, Curis Inc. is 2.06 times less risky than BioGaia. It trades about -0.07 of its potential returns per unit of risk. BioGaia AB is currently generating about -0.23 per unit of risk. If you would invest 487.00 in Curis Inc. on April 25, 2012 and sell it today you would lose (21.00) from holding Curis Inc. or give up 4.31% of portfolio value over 30 days.

Diversification

Significant diversification
Overlapping area represents amount of risk that can be diversified away by holding Curis Inc. and BioGaia AB in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.05
 Parameters
Time Period1 Month [change]
DirectionPositive BGAIF.PK Moved Up vs CRIS
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between CRIS and BGAIF with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between CRIS and BGAIF to your reader
 
Get social with Correlation between CRIS and BGAIF
 Share Correlation between CRIS and BGAIF 
Share Share Correlation between CRIS and BGAIF
    
    
 
       
Predicted Return Density
Expected Daily Returns   
CRIS  BGAIF  

Curis Inc.

 
    
    
Curis
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Curis Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Amgen Inc. vs. Curis Inc.
Gilead Sciences Inc. vs. Curis Inc.
Biogen Idec Inc. vs. Curis Inc.
Celgene Corporation vs. Curis Inc.
Alexion Pharmaceuticals Inc. vs. Curis Inc.
Vertex Pharmaceuticals Incorporated vs. Curis Inc.
  

BioGaia AB

 
    
    
BioGaia
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days BioGaia AB has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Federal National Mortgage Association vs. BioGaia AB
KDDI CORP vs. BioGaia AB
SK Innovation vs. BioGaia AB
A.P. M vs. BioGaia AB
Citigroup Inc. vs. BioGaia AB
AngloGold Ashanti Ltd. vs. BioGaia AB
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting